preloder

投资于 LONGEVITY

长寿的全方位生活条件
我们知道如何改善你的生活
成为分散的生态系统的一部分
GLOBAL LONGEVITY

Private ICO round successfully completed.

1 LONGEVITY = 0,00001 ETH
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.
关于项目
全球长寿是一个分散的,可扩展的生态系统,为质量长寿创造了全方位的生活条件。 它利用世界科学的所有最新成果,在IT平台上进行基于区块链,神经网络和机器学习的个性化生命管理。
Longevity 软件令牌由 Global Longevity 生成,并为其所有者提供对公司当前和未来服务的访问权限。 Global Longevity 体现了长寿市场上最好的技术和多年的经验。

LONGEVITY 是实用的东西

作为非金融工具,它为业主提供全球长寿服务和可在全球长寿市场购买的产品。

我们的任务

全球长寿的使命是通过使用先进的长寿科学技术,为人们提供真正的机会来延长生命。

成为分散的生态系统的一部分

GLOBAL LONGEVITY

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

不要成为生活中的客人

成为她的主人 !

我决定永远活着。 所以一切都好

未知的作者

可以为 LONGEVITY 购买

海边的公寓和土地(购买和租赁)

希望在迷人的度假村和休闲区购买房产也开辟了广阔的前景和机遇。 在外国公民中特别受欢迎的是格鲁吉亚 – 阿贾里亚地区,特别是巴统市 – 一个港口城市,在那里他们有独特的风味。

诊断和治疗

对身体的完整诊断意味着全面检查,这是在特殊装置的帮助下和通过各种测试进行的。 获得的数据使我们能够全面了解人类健康状况,其内部器官和新的形态,包括良性和恶性。

法律援助

所提供服务的高效率源于指导我们的原则。 这是一个专业级别的律师培训,对每个客户的个人方法,对服务质量的责任,关注他们的校长的愿望和利益。

药理产品

该行业涉及药物的研究,开发,大规模生产,市场研究和分销,主要用于预防,缓解和治疗疾病。 目前,制药业是最成功的行业之一。

全球长寿的有机食品

在世界各地,有机食品的生产正在蓬勃发展。 与现代技术生产的产品相比,这种食品平均含有10-50%的维生素,矿物质和其他营养素。 有机食品可改善健康,增强免疫力,尤其适用于儿童,孕妇和哺乳期妇女。

旅游服务

如果你喜欢呼吸新鲜的风,醒来听鸟儿的歌声和溪流的潺潺声,你想要进入奇妙的冒险世界 – 你来对了地方!

矿业

GlobalLongevity在该领域的经验帮助我们与领先的设备制造商和技术公司建立了合作伙伴关系,这将使我们能够成功并有利地帮助我们的客户在未来开展采矿业务。

ICO和STO促销

只有在专业技能得到适当组合的情况下,才能成功实现所有目标。 我们团队的每个成员都是技术娴熟的专业人士,专注于范围。

绝对是,即使1Longevity(0,00001 ETH)的成本等于0,001 ETH,我们的全球长寿市场也会提供全部已发行代币的商品和服务。因此,今天令牌的初始增长潜力 是9900%。
Name: LONGEVITY
Ticker: LGV
Type: ERC-20
Platform: Ethereum
Token Type: Utility
Token Price: 0,00001 ETH
Soft Cap: none
Hard Cap: 1.000.000 LGV
Return on Invest: long-term token value increase
Purchase methods accepted: All Leading Crypto and Fiat
Total token supply: 100.000.000.000 LGV
Private-sale & Public Sale: 89.000.000.000 LGV
Team: 5.000.000.000 LGV
Advisors: 3.000.000.000 LGV
Marketing Activities and Bounty: 3.000.000.000 LGV

令牌分布的百分比

分配和使用资金

NOTES

  • Team’s token will be locked for 30 months after the Private-sale & Public Sale
  • Tokens for Marketing team and Bounty will be locked for 6 months after the Private-sale & Public Sale
Investor Exclusions: Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia.
路线图
Jan 2014
Official opening Global Longevity Institute
Mar 2014
Approval of the concept of creating an ecosystem within the program of Global Longevity
Nov 2014
Selection and approval of the region for the pilot project of Global Longevity
Jan 2015
Initiation of a material base for a pilot project of Global Longevity
May 2017
Completion of work on the creation of a material basis for the pilot project of Global Longevity
Jul 2017
Deciding on the implementation of blockchain and cryptocurrency in the project of Global Longevity
Jan 2018
Start preparation for ICO Global Longevity
Dec 2018
Cryptocurrency issue Longevity
May 2019
Start Pre ICO
Jun 2019
Start ICO
Jul 2020
Full launch of the Global Longevity project
团队和顾问

Elina Mahzhalii

CEO (Chief Executive Officer),
CEO Global Longevity Institute

Wolfgang Stremmel

Professor of Internal Medicine IV

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

Akaki Lomadze

Doctor of Medicine, Male Health Expert

迈出一步 长寿!

伙伴
新闻与出版物
(出版物计划出版物)
请与我们联系

 

Global Longevity Disclaimer

Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.